BYPAL
ByPal is an app-based classified portal for buying, selling, renting and lending of pre-owned products.
BYPAL
Social Links:
Industry:
Apps E-Commerce Information Technology Internet
Founded:
2016-01-01
Address:
Ra'anana, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.bypal.co
Total Employee:
1+
Status:
Active
Contact:
972-054-7699912
Email Addresses:
[email protected]
Technology used in webpage:
LetsEncrypt Google Tag Manager Apache Global Site Tag WordPress 5.9 Smart Slider 3
Similar Organizations
Easy Home Fix
Easy Home Fix is a mobile platform for repair and maintenance needs.
Petbelio
Petbelio is an Indonesia Pet Technology Company specializing in social, on-demand multi-service and marketplace.
More informations about "ByPal"
BPal | Portefeuille Immobilier
Bpal investit dans des projets immobiliers de qualité qui assurent une stabilité et une sécurité des rendements. Le portefeuille de placements visé inclut des participations dans des immeubles …See details»
WHO issues rapid communication on key updates to the …
Aug 23, 2024 The new regimens recommended in this update represent alternative treatment options for those patients not eligible to receive the BPaLM/BPaL regimen.The complete and …See details»
Our Mission - TB Alliance
Our Mission TB Alliance is a not-for-profit organization dedicated to the discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs that are available to those who need them. We envision a world where …See details»
New Drug-Resistant TB Treatments Reach Patients in …
ISLAMABAD and PRETORIA (9 November 2023)—The Association for Social Development (ASD) has registered 206 participants with drug-resistant tuberculosis (DR-TB) in Pakistan through a pilot program for treatment with …See details»
NEW GLOBAL RESEARCH: FOUR NEW, IMPROVED DRUG …
Nov 15, 2023 First multi-country research finds new BPaL treatment is ‘highly effective’; ... was about 63% prior to the uptake of new regimens, according to the World Health Organization …See details»
Access to the BPaL Regimen - TB Alliance
Clicking on a country's name will open the World Health Organization's TB profile for that country. PATHWAYS TO ACCESS: Regulatory approval of BPaL is indicated in countries where the …See details»
Global adoption of 6-month drug-resistant TB …
Jan 5, 2024 Background The WHO has issued a call to action urging countries to accelerate the rollout of new WHO-recommended shorter all-oral treatment regimens for drug-resistant TB (DR-TB), which remains a public-health crisis. …See details»
New treatment for TB - World Health Organization (WHO)
Jun 27, 2023 The World Health Organization (WHO) has regularly evaluated new evidence on the use of specific drug compositions and combinations of regimens of different durations. …See details»
FrequentlyAsked Questions - World Health Organization (WHO)
Programme of the World Health Organization (WHO), the Global Fund to Fight AIDS, Tuberculosis and Malaria, the ... - The BPaL regimen is defined as a novel treatment regimen …See details»
People with TB in Ukraine are the first to receive groundbreaking …
Nov 23, 2020 The BPaL regimen was developed by the non-profit TB Alliance and is implemented in Ukraine by the local NGO Organization for Appropriate Technologies in Health …See details»
Introducing BPaL: Experiences from countries supported under the …
Nov 19, 2024 Background Previously, drug-resistant tuberculosis (DR-TB) patients were treated with long, toxic, and relatively ineffective regimens. However, in recent years, there have been …See details»
Update of drug-resistant tuberculosis treatment guidelines: A …
Drug-resistant tuberculosis (DR-TB) remains a major global health threat, with an estimated burden of 450,000 (95% CI: 399,000-501,000) new cases of rifampicin-resistant TB (RR-TB) in …See details»
TB Alliance | Putting science to work for better, faster TB cures.
New Treatments Researching Faster Cures TB Alliance is not just developing new drugs, but changing the way TB drugs are developed. Learn More [view:homepage_topic_links=block_1] …See details»
Essentials steps for introduction and scale-up of the BPaL …
The BPaL containing regimens Date: Thursday, 18 November 2021 Time: 13:00 to 16:00 CEST ... DR-TB and TB/HIV co-infection in high-burden countries and resource-poor settings (WHO …See details»
TB Alliance Statement on New World Health Organization Rapid ...
May 3, 2022 BPaL regimen for treatment of highly drug-resistant tuberculosis under operational research conditions: Ukraine experience, safety, and end of treatment outcomes [Conference …See details»
WHO BPaLM Accelerator Platform - World Health Organization …
Mar 13, 2024 The WHO BPaLM Accelerator Platform was established in January 2023, right after the update of WHO guidelines on the treatment of drug-resistant TB in 2022. The …See details»
Provisional CDC Guidance for the Use of Pretomanid as part of a …
Feb 8, 2024 At baseline, prior to BPaL initiation, persons should undergo blood pressure measurement and an ECG to screen for prolonged QT interval. Persons receiving the BPaL …See details»
Realizing our “Triple-A Mandate” - TB Alliance
Aug 14, 2023 Four years ago, TB Alliance secured the first regulatory approval from the United States Food and Drug Administration (US FDA) for the new anti-tuberculosis drug, …See details»
Pretomanid and BPaL Regimen for Treatment of Highly-Resistant …
CO-10 BPaL: All-Oral, Short, Fixed Regimen ... World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 2. World Health Organization Global TB Report, 2018. …See details»
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis
Dec 21, 2022 The BPaLM regimen included BPaL plus moxifloxacin at a dose of 400 mg daily for 24 weeks, and the BPaLC regimen included BPaL plus clofazimine at a dose of 100 mg …See details»